JOHN BUCKLAND: Open Payments
NPI 1871623413 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$438 in 21 payments from 6 companies in 2025. Trend: 2023 $247 · 2024 $323 · 2025 $438
Food & beverage: $438
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 8 | $168 |
| Neurocrine BioSciences, Inc. | 5 | $120 |
| Teva Pharmaceuticals USA, Inc. | 4 | $72 |
| Alkermes, Inc. | 2 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
Products named: COBENFY, INGREZZA, UZEDY, ARISTADA, ABILIFY ASIMTUFII, INVEGA SUSTENNA.
Industry payments across SC — which companies pay providers there.
